Astrazeneca Pharma India Ltd (ASTRAZEN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,188.15",
    "chg": 96.8,
    "chgp": "1.2%",
    "dir": 1,
    "prev_price": "8,091.35",
    "mcapval": "20,209.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE203A01020",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "14:10 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "2.67 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downturn-4137033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AstrazenecaPhar_technicaldot_4137033.png",
        "date": "2026-08-05 08:04:48",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects growing concerns over its price action and technical health amid a challenging market environment for pharmaceuticals and biotechnology small-caps."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4134927",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AstrazenecaPhar_technicaldot_4134927.png",
        "date": "2026-08-04 08:07:11",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early 2026. Despite a 2.37% gain on 4 Aug 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum measures. This analysis delves into the evolving technical landscape of this small-cap pharmaceutical player, contextualising its recent price action and longer-term trends against sector and benchmark indices."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4132366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AstrazenecaPhar_mojoScore_4132366.png",
        "date": "2026-08-02 10:10:16",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4115151",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AstrazenecaPhar_mojoScore_4115151.png",
        "date": "2026-07-22 10:10:03",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4097003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AstrazenecaPhar_mojoScore_4097003.png",
        "date": "2026-07-11 10:10:18",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 11 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4078812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_mojoScore_4078812.png",
        "date": "2026-06-30 10:10:31",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downgrade-4077911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_technicaldot_4077911.png",
        "date": "2026-06-30 08:05:54",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and momentum oscillators, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4063132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_mojoScore_4063132.png",
        "date": "2026-06-19 10:10:57",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4037395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_mojoScore_4037395.png",
        "date": "2026-06-08 10:10:23",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 379,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday August 10 2026",
      "datetime": "04-Aug-2026",
      "details": "Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Monday August 10 2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the quarter ended June 30 2026. We also confirm that the Trading Window remains closed for all Designated Persons from June 16 2026 to August 12 2026 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "30-Jul-2026",
      "details": "Please find the enclosed document of the Company in relation to the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "29-Jul-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "10 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1800%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downturn

2026-08-05 08:04:48

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects growing concerns over its price action and technical health amid a challenging market environment for pharmaceuticals and biotechnology small-caps.

Read full news article

Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-04 08:07:11

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early 2026. Despite a 2.37% gain on 4 Aug 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum measures. This analysis delves into the evolving technical landscape of this small-cap pharmaceutical player, contextualising its recent price action and longer-term trends against sector and benchmark indices.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-08-02 10:10:16

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-07-22 10:10:03

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-07-11 10:10:18

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 11 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-06-30 10:10:31

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-06-30 08:05:54

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and momentum oscillators, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-06-19 10:10:57

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-06-08 10:10:23

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News